Emerging Diagnostic Technologies in the Changing U.S. Market

Published - Jan 2013| Analyst - Andrew McWilliams| Code - HLC124A
Market Research Report Single User License: $2,750 Member Price: FREE

Report Highlights

The U.S. emerging diagnostic technologies market was valued at $880 million in 2011 and should reach $1.2 billion in 2012. Total market value is expected to reach $3.2 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 20.9%.

Report Scope

This report addresses the U.S. market for emerging diagnostic technologies.  Of course, terms such as emerging or new are relative in a rapidly evolving market such as medical diagnostics.  Thus, this report pragmatically defines emerging diagnostic technologies as those that are only in limited commercial use and/or in advanced development as of 2012.  Also included are certain technologies, such as telemedicine, that have been in use for more than a few years, but which have the potential today to cause a fundamental or paradigm shift in the way diagnoses are performed.  The technologies covered fall into the following categories:

  • Ultrasound.
  • Magnetic resonance imaging.
  • Nuclear medicine.
  • Computed tomography.
  • Photonics, optics and spectroscopy.
  • Hybrid imaging technologies.
  • Telediagnosis.
  • Laboratory information systems.
  • Diagnostic decision support systems.
  • Imaging agents.
  • Terahertz technology.
  • Wireless devices.
  • Other technologies.

The format of the study includes the following elements:

  • Summary.
  • Definitions.
  • Developments in enabling technologies.
  • Key end-user segments.
  • Market environment (legal and regulatory, standards, trends in the healthcare industry, demographic and economic trends, other market drivers and barriers to deployment).
  • Emerging diagnostic technologies and products.
  • Detailed market estimates and projections, by type of diagnostic technology and product, 2011 to 2017.
  • Supplier profiles.
  • Patent analysis.

Analyst Credentials

Andrew McWilliams spent more than 25 years as a consultant with Ernst & Young, McKinsey & Company and A.T. Kearny focused on manufacturing before segueing into research analysis. He has been covering myriad technology categories for BCC Research for more than 15 years. McWilliams has a BA from Princeton University and an MA from Harvard University. He has worked in more than 40 countries and he resides in the greater Boston area.

Select reports include:

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
RELATED REPORTS
Share This Report